Laurent Peyrin-Biroulet to Drug Approval
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Drug Approval.
Connection Strength
0.046
-
Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing. Immunotherapy. 2019 05; 11(7):565-575.
Score: 0.024
-
Clinical development of biologicals and biosimilars - safety concerns. Expert Rev Clin Pharmacol. 2017 06; 10(6):567-569.
Score: 0.021